NDA 073107 describes ACETAMINOPHEN, which is a drug marketed by Able, Perrigo New York, Roxane, Taro Pharms North, Ohm Labs, Perrigo, Ranbaxy, Ranbaxy Labs Ltd, Teva, Actavis Mid Atlantic, Dava Pharms Inc, Hi Tech Pharma, Mikart, Pharm Assoc, Vintage Pharms, Wockhardt, Am Therap, Amneal Pharms Ny, Aurolife Pharma Llc, Duramed Pharms Barr, Everylife, Halsey, Kv Pharm, Lederle, Mallinckrodt Inc, Mutual Pharm, Puracap Pharm, Purepac Pharm, Sandoz, Superpharm, Usl Pharma, Valeant Pharm Intl, Vintage, Vitarine, Warner Chilcott, Watson Labs, Watson Labs Florida, Whiteworth Town Plsn, Cent Pharms, Gavis Pharms, Wraser Pharms Llc, Boca Pharma Llc, and West-ward Pharm Corp, and is included in one hundred and twelve NDAs. It is available from two suppliers. Additional details are available on the ACETAMINOPHEN profile page.
The generic ingredient in ACETAMINOPHEN is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.
|Active Rx/OTC/Discontinued:||DISCN||Dosage:||SUPPOSITORY; RECTAL||Strength||325MG|
|Approval Date:||Feb 27, 1995||TE:||RLD:||No|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.